Gut Microbiota in Multiple Sclerosis: Possible Influence of Immunomodulators

Objectives Differences in gut bacteria have been described in several autoimmune disorders. In this exploratory pilot study, we compared gut bacteria in patients with multiple sclerosis and healthy controls and evaluated the influence of glatiramer acetate and vitamin D treatment on the microbiota....

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of investigative medicine Ročník 63; číslo 5; s. 729 - 734
Hlavní autori:	Cantarel, Brandi L., Waubant, Emmanuelle, Chehoud, Christel, Kuczynski, Justin, DeSantis, Todd Z., Warrington, Janet, Venkatesan, Arun, Fraser, Claire M., Mowry, Ellen M.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Los Angeles, CA SAGE Publications 01.06.2015
Predmet:	Adjuvants, Immunologic - pharmacology Adjuvants, Immunologic - therapeutic use Adult Cholecalciferol - pharmacology Cholecalciferol - therapeutic use Dietary Supplements Female Gastrointestinal Microbiome - drug effects Gastrointestinal Microbiome - physiology Glatiramer Acetate - pharmacology Glatiramer Acetate - therapeutic use Humans Immunologic Factors - pharmacology Immunologic Factors - therapeutic use Middle Aged Multiple Sclerosis, Relapsing-Remitting - diagnosis Multiple Sclerosis, Relapsing-Remitting - drug therapy Pilot Projects gut microbiome autoimmunity glatiramer acetate multiple sclerosis vitamin D
ISSN:	1081-5589, 1708-8267
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!